[Clinical experience with bromocriptine, a central dopaminergic stimulator].
D000368:Aged; D000547:Amantadine / Q000627:therapeutic use; D001971:Bromocriptine / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D055598:Chemical Phenomena; D002621:Chemistry; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004873:Ergolines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*; D010919:Placebos; D014282:Trihexyphenidyl / Q000627:therapeutic use
D004873:Ergolines; D010919:Placebos; D001971:Bromocriptine; D007980:Levodopa; D014282:Trihexyphenidyl; D000547:Amantadine
Klinische Erfahrungen mit Bromocriptin, einem zentralen dopaminergen Stimulator